The Battle Between Innovation and Bullying Tactics: TAV 7

Aug.12.2022
The Battle Between Innovation and Bullying Tactics: TAV 7
The 7th episode of TAV 7 focuses on the battle between innovation and bullying tactics in reducing tobacco harm.

The seventh episode of "The Advocates' Voice" (TAV 7) is titled "The Battle between Innovation and Bullying Tactics," and is organized by the Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA).


The group is composed of public relations experts and medical publishing observer Jena Fetalino, who emphasized that the abuse suffered by advocates of tobacco harm reduction (THR) and the industry reflects only one thing. According to Ms. Fetalino, "This shows that anti-smoking groups no longer have a reason to defend their case and resort to defamation to demonize the smoking industry, nicotine consumers, THR advocates, and the entire THR.


She urged THR advocates around the world not to remain silent but to confront "fake news" head-on. "Their response should be direct, straightforward, and simple so that people can understand the issue, no matter how complicated it may be. Even if attackers choose to focus on areas below the seat belt, we should remain calm, state the facts to provide information, not insults... We should have enough patience to clarify the issue by stating our position, denying inaccurate information, and correcting mistakes." We should have the facts and evidence at our fingertips. In the end, readers will discover what is true," she said.


A new form of attack.


The director of the Pakistan Association of Smoking Alternatives (ASAP) has stated that the reduction of tobacco harm is now facing new attacks. "Once opponents of THR can no longer attack the science, they will turn their focus towards advocates and consumers. These attacks must be based on facts, to expose any flaws in their narrative and to show that you are not an easy target.


The Director of the Thailand Tobacco Control Board (ECST), Asa Saligupta, has stated that the positive results achieved by reducing the harm caused by tobacco are worth the effort. Saligupta said: "If everyone thinks 'why bother doing this, it's too hard,' then nothing will happen... I myself have re-evaluated my own health after quitting smoking and going back to it. I look at my friends, especially my son, who quit smoking with the help of tobacco control efforts... without reducing tobacco harm, it would not be possible. They have prospered because of it.


Finally, Fasalinos emphasized the importance of patience and perseverance when concluding the discussion. He stated that it is necessary to maintain patience while adhering to our principles and moral standards and not yield to blackmail. This is the message he wished to convey.


Statement:


This article is compiled from third-party information and is only intended for industry exchange and learning purposes.


This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity or accuracy of the article's content. The translation of this article is only intended for industry-related discussion and research purposes.


Due to limitations in our ability to translate accurately, the translated version of the article may not fully reflect the original text. Please refer to the original article for accuracy.


2FIRSTS maintains complete alignment with the Chinese government on all domestic, Hong Kong, Macau, Taiwan, and foreign related statements and positions.


The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us for removal.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

WHO’s First Global Report on Nicotine Pouches: Harm Reduction Questions Remain Amid Global Regulatory Warning
WHO’s First Global Report on Nicotine Pouches: Harm Reduction Questions Remain Amid Global Regulatory Warning
Ahead of World No Tobacco Day 2026, WHO released its first global report on nicotine pouches, warning that rapid market growth, youth-oriented marketing and weak regulation are converging. 2Firsts views the report as an important warning, but not a complete risk assessment, with harm-reduction questions still unresolved.
Special Report
May.17
Philip Morris Says Its Smoke-Free Transition in Spain Now Has Economic Impact Above EUR 3.3 Billion
Philip Morris Says Its Smoke-Free Transition in Spain Now Has Economic Impact Above EUR 3.3 Billion
Philip Morris said it is accelerating its transition toward smoke-free products in Spain and claimed that the related economic impact now exceeds EUR 3.3 billion. Philip Morris also said that more than 90% of nicotine consumption in Spain still comes from conventional cigarettes, leaving room for growth in smoke-free categories, while regulation and taxation remain major obstacles in its view.
Apr.21 by 2FIRSTS.ai
 FDA Begins Review of 22nd Century’s VLN MRTP Renewal Applications
FDA Begins Review of 22nd Century’s VLN MRTP Renewal Applications
The U.S. Food and Drug Administration (FDA) has initiated scientific review of renewal applications for 22nd Century Group’s VLN reduced-nicotine cigarettes under the Modified Risk Tobacco Product (MRTP) pathway, with current authorizations set to expire in December 2026.
News
May.13
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Summary Ispire Technology announced a strategic joint venture with Chinese pharmaceutical company Jincheng Pharma to manufacture and commercialize nicotine pouch products. The partnership combines pharmaceutical-grade production capabilities with Ispire’s global regulatory infrastructure and distribution network as the company expands beyond vaping hardware into oral nicotine products.
Business
May.13
CBP and FDA Seize 18 Million Illegal Vapes Worth $175 Million in Maritime Cargo Operation
CBP and FDA Seize 18 Million Illegal Vapes Worth $175 Million in Maritime Cargo Operation
U.S. Customs and Border Protection (CBP) announced that more than 18 million illegal e-cigarettes valued at over $175 million were seized during “Operation Red Mist,” a joint enforcement initiative involving the U.S. Coast Guard and the FDA. The operation primarily targeted maritime vape shipments originating from China and focused on combating illicit importation, transportation, and distribution activities.
Regulations
May.14
 BAT Raises Growth Outlook for Smokeless Products as Velo and Vuse Gain Momentum
BAT Raises Growth Outlook for Smokeless Products as Velo and Vuse Gain Momentum
British American Tobacco (BAT) has raised its growth outlook for smokeless products, forecasting “mid-teens” growth for its new category portfolio, including vaping and nicotine pouch products, while global cigarette volumes are expected to decline further.
BAT
Jun.02